Taiwan TJCIP International Patent Office
Home > Recruit & news > [Patent Filing in Taiwan, TJIP Firm] A Settlement of Patent Lawsuit between TWi Pharmaceuticals and Allergan

2017-01-16 人氣:2797[Patent Filing in Taiwan, TJIP Firm] A Settlement of Patent Lawsuit between TWi Pharmaceuticals and Allergan

 TWi Pharmaceuticals, Inc. (TWi) announced that it has entered an agreement with Allergan, Inc. that settles the lawsuit filed suit against TWi on July, 2016 regarding TWi’s generic version of Restasis. The agreement provides for the dismissal of all litigation related to TWi’s generic version of Restasis. TWi pointed out that the dismissal of the litigation will permit the US FDA to grant final approval of TWi’s generic product 180 days after the first generic applicant begins commercial marketing of its approved product or sooner if FDA determines that there is no first generic applicant. TWi can thus avoid further litigation cost on its Restasis version launching.

回列表頁

台灣仕誠國際專利事務所

  • 公司簡介
  • 關於我們
  • 業務內容
  • 法規最新消息及人才招募
  • 聯絡我們
  • 服務據點
  • - Exhibition Activities -
  • - News of Intellectual Property -
  • - News of Patent -
  • - Introduction of Patent System in Taiwan and the world -
  • - News of Intellectual Property Law -
  • - Patent Practice -
  • - Q&A -
  • - Recruit -
Home|Company|About|Service|News & Recruit|Contact|Offices
TEL:886-2-27472000 FAX:886-2-27627970 Copyright© 2010 TJIP. All rights reserved Taiwan TJIP International Patent Trademark Firm Design by 一化網頁設計